NCT00694980 A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis Status COMPLETED Phase PHASE1
NCT00679432 (CB-01-02/01) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis Status COMPLETED Phase PHASE3
NCT00679380 (CB-01-02/02) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis Status COMPLETED Phase PHASE3
NCT00663819 Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses Status TERMINATED Phase NA
NCT00659802 Phase II Study of HMPL-004 in Patients With Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT00656890 A Study of MDX-1100 in Subjects With Active Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT00643071 Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis Patients Status COMPLETED Phase PHASE3
NCT00628433 Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis Status COMPLETED Phase PHASE1/PHASE2
NCT00622557 General Surgical Outcomes Quality Improvement Database (UH-SOCRATES) Status COMPLETED Phase N/A
NCT00620126 The Home Telemanagement (UC HAT) Trial for Patients With Ulcerative Colitis Status COMPLETED Phase PHASE3
NCT00619489 Long Term Safety of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease Status COMPLETED Phase PHASE2
NCT00618228 Bioequivalency Study of Balsalazide Capsules Under Fasting Conditions Status COMPLETED Phase NA
NCT00618202 A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Balsalazide Disodium 750 mg Capsules Under Fasting Conditions Status COMPLETED Phase NA
NCT00606346 A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease Status ACTIVE_NOT_RECRUITING Phase N/A
NCT00604422 Evaluation of the PillCam™ Colon Capsule Endoscopy (PCCE) in Detection & Classification of Ulcerative Colitis Status COMPLETED Phase N/A
NCT00586807 Metabolic Response to Infliximab in Pediatric Ulcerative Colitis Status TERMINATED Phase NA